Candida auris: A multi-drug resistant pathogen

Candida auris is an emerging pathogen that results in nosocomial infections and is considered a serious global health problem. It was first observed as a novel  Candida species in 2009 and has been isolated in 35 countries.

C. auris may cause invasive infections associated with high mortality. It is considered a multi-drug resistant species, having variable resistance patterns to many typical antifungal agents used to treat other Candida infections.

The CDC is concerned about C. auris for three main reasons:

  1. It is often multidrug-resistant, meaning that it is resistant to multiple antifungal drugs commonly used to treat Candida infections. Some strains are resistant to all three available classes of antifungals.
  2. It is difficult to identify with standard laboratory methods, and it can be misidentified in labs without specific technology. Misidentification may lead to inappropriate management.
  3. It has caused outbreaks in healthcare settings. For this reason, it is important to quickly identify C. auris in a hospitalized patient so that healthcare facilities can take special precautions to stop its spread.

Candida Auris: What is it? Can we stop it? | ARC IPC

Resources for Candida auris:

General Information:
Infection Prevention:
For Healthcare Providers:
Webinars

The Changing Landscape of Antimicrobial Resistance Following the COVID-19 Pandemic (February 8, 2023, 11am CST)

This webinar is presented by the Alabama Regional Center for Infection Prevention and Control Training and Technical Assistance. Antimicrobial resistance is one of the largest health threats to healthcare systems and the COVID-19 pandemic has identified weaknesses that have allowed for transmission within hospitals. In this talk, Dr. Rachael Lee, assistant professor in the Division of Infectious Diseases and healthcare epidemiologist for the UAB Health System will provide a summary of the epidemiology of antimicrobial resistant bacteria in a pandemic era. This webinar is co-sponsored by the Alabama Regional Center for Infection Prevention and Control, Region IV Public Health Training Center, and Deep South Center for Occupational Health and Safety.  

The Deep South Center for OH&S is an approved provider of continuing education units for nurses by the AL Board of Nursing (Provider ABNP0420 Expiration Date 12/22/2025) and has awarded this program 1.0 CEUs.

                                         

Protect and Preserve: Priorities of Antimicrobial Stewardship (November 1, 2022 12pm CST)

This webinar is presented by the Alabama Regional Center for Infection Prevention and Control Training and Technical Assistance. Antimicrobials are essential for modern medicine; however, they become less effective over time. In addition, adverse effects and other negative consequences of antimicrobial use are not uncommon. This presentation, Dr. Matthew Brown will provide an overview of antimicrobial stewardship and how it can help protect patients and preserve the utility of these important medications. This webinar was co-sponsored by the Alabama Regional Center for Infection Prevention and Control, Deep South Center for Occupational Health & Safety, and the Region IV Public Health Training Center.

The Deep South Center for OH&S is an approved provider of continuing education units for nurses by the AL Board of Nursing (Provider ABNP0420 Expiration Date 12/22/2025) and has awarded this program 1.0 CEUs.

Dr. Matthew Brown, Pharm.D., BCPS, BCIDP is the supervising pharmacist for antimicrobial stewardship and the director of the PGY2 infectious diseases pharmacy residency program at UAB Hospital in Birmingham, AL.